Transcripts Edgewise Therapeutics, Inc.

Actions

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 24/07/2026			Varia. 5j.	Varia. 1 janv.
40,84 ^USD	+3,95 %		+2,72 %	+64,58 %

10/07	Servier Pharmaceuticals LLC a finalisé l'acquisition du Sevasemten et de l'activité dystrophie musculaire d'Edgewise Therapeutics, Inc. (NasdaqGS:EWTX).	CI
09/07	Edgewise Therapeutics : l'EDG-7500 entre dans une période riche en catalyseurs réglementaires, selon Oppenheimer	MT

17/06	Transcript : Edgewise Therapeutics, Inc. - Special Call
13/01	Transcript : Edgewise Therapeutics, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 08:15 AM
04/12	Transcript : Edgewise Therapeutics, Inc. Presents at Piper Sandler 37th Annual Healthcare Conference, Dec-02-2025 02:00 PM
26/06/25	Transcript : Edgewise Therapeutics, Inc. - Special Call
09/06/25	Transcript : Edgewise Therapeutics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 03:20 PM
02/04/25	Transcript : Edgewise Therapeutics, Inc. - Special Call
13/01/25	Transcript : Edgewise Therapeutics, Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-13-2025 01:30 PM
18/12/24	Transcript : Edgewise Therapeutics, Inc. - Special Call
16/12/24	Transcript : Edgewise Therapeutics, Inc. - Special Call
19/09/24	Transcript : Edgewise Therapeutics, Inc. - Special Call
15/05/24	Transcript : Edgewise Therapeutics, Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-15-2024 03:35 PM
16/04/24	Transcript : Edgewise Therapeutics, Inc. - Special Call
09/06/21	Transcript : Edgewise Therapeutics, Inc. Presents at Goldman Sachs 42nd Annual Global Healthcare Conference, Jun-09-2021 05:30 PM